铁化相关分子的血清水平与稳定的COPD的结果之间的关联:一项探索性前性观察性研究
Cristina Ghadban1,2,3, Mayte García-Unzueta2,3,4, Juan Agüero1
1Department of Pulmonology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Internal and emergency medicine
|June 21, 2025
概括
铁亡标志物,包括可溶性转激素受体1 (sTfR1) 和谷氨过氧化酶4 (GPX4),在COPD患者中不同. 升高的sTfR1和低的GPX4预测了运动能力的降低和COPD恶化风险的增加.
科学领域:
- 生物化学 生物化学
- 肺部病理学 肺部病理学
- 细胞生物学 细胞生物学
背景情况:
- 铁,一种依赖于铁的细胞死亡,与慢性阻塞性肺病 (COPD) 病理生理学有关.
- 关键的铁化相关因素 (ACSL4,sTfR1,GPX4,AIFM2) 调节铁代谢,氧化应激和脂质过氧化.
研究的目的:
- 为了研究稳定的COPD门诊患者的铁化相关因素的血清水平.
- 为了将这些水平与COPD临床表现,运动能力和恶化风险相关联.
主要方法:
- 在179名稳定的COPD患者和57名健康吸烟者中测量了ACSL4,sTfR1,GPX4和AIFM2的血清水平.
- 评估了临床特征,六分钟的步行距离和12个月的恶化事件.
主要成果:
- 与对照组相比,COPD患者表现出较高的sTfR1和较低的GPX4水平 (p<0.004).
- 在COPD组中,sTfR1/GPX4比率显著更高 (p=0.001).
- 低的GPX4和高的sTfR1/GPX4独立预测了不良的六分钟步行距离和中度/严重恶化的风险增加.
结论:
- 在COPD患者中,血清铁化相关因子水平发生变化.
- 升高的sTfR1,降低的GPX4和sTfR1/GPX4比率是预测COPD进展和恶化风险的潜在生物标志物.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
COPD: Pathogenesis and Clinical Features
540
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
540
COPD: Management Using Bronchodilators and Corticosteroids
329
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
329
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


